Biofidelity is a startup based in the United Kingdom, most recent round Series B, 1 tracked investor.
Biofidelity is a company founded in 2018 headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Biofidelity develops innovative molecular assays that enable precise and rapid detection of genetic mutations in cancer patients, improving treatment selection and monitoring.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.